Varicella Vaccine: a Molecular Variant That May Contribute to Attenuation-Reference-Cited by-同舟云学术

Varicella Vaccine: a Molecular Variant That May Contribute to Attenuation

Published:2022-12-20 Issue:6 Volume:13 Page:
ISSN:2150-7511
Container-title:mBio
language:en
Short-container-title:mBio

Author:

Gershon Anne A.¹^ORCID,Gershon Michael D.²

Affiliation:

1. Department of Pediatrics, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA

2. Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA

Abstract

Varicella was troublesome when varicella vaccine (vOka) was licensed in the United States. Varicella’s yearly death toll was ~100, indirect costs were massive, and varicella threatened immunocompromised children.

Funder

HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

American Society for Microbiology

Subject

Virology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/mbio.03120-22

Reference16 articles.

1. LIVE VACCINE USED TO PREVENT THE SPREAD OF VARICELLA IN CHILDREN IN HOSPITAL

2. Varicella Vaccines

3. A Variant Allele in Varicella-Zoster Virus Glycoprotein B Selected during Production of the Varicella Vaccine Contributes to Its Attenuation

4. Doctors weigh the costs of a chicken pox vaccine;Rosenthal E;New York Times,1993

5. Effectiveness Over Time of Varicella Vaccine

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A booster administration of the OKA/SK strain causes fatal disseminated varicella in an immunocompetent child;Journal of Medical Virology;2024-07